Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Artelon
AddedFeb 15, 2024
UpdatedJun 18, 2026
Artelon

Artelon

Public

Artelon, a med-tech firm, specializes in bio-textile design for tendon/ligament reconstruction and tissue restoration.

HQ
Marietta, GA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize tendon and ligament reconstruction, Artelon is a medical technology company that specializes in the development of bio-textiles. Their core vision focuses on enhancing patient mobility and stability through innovative synthetic materials. Artelon's primary product, FLEXBAND, is designed for the kinematic reinforcement of tendons and ligaments, aiming to restore both stability and motion. The company targets the orthopedic market, particularly focusing on patients requiring tissue reconstruction.

Artelon has garnered attention through its advanced bio-textile technology, attracting notable investors and medical professionals in the field. The company's achievements include successful clinical outcomes and widespread adoption of their FLEXBAND product in surgical procedures. Artelon's impact is evident in improved patient recovery times and enhanced quality of life for those undergoing tendon and ligament reconstruction.

Artelon - Similar Companies

Atreon Orthopedics logo

Atreon Orthopedics

atreonortho.com

Articulinx logo

Articulinx

articulinx.com

Tela Bio logo

Tela Bio

telabio.com

Artio Medical logo

Artio Medical

Artivion logo

Artivion

artivion.com

Ultraflex Systems logo

Ultraflex Systems

MiMedx Group logo

MiMedx Group

mimedx.com

TendoNova logo

TendoNova

tendonova.com

Flex Biomedical logo

Flex Biomedical

flexbio.com

Adient Medical logo

Adient Medical

adientmedical.com

Articulate Biosciences logo

Articulate Biosciences

articulatebio.com

Arsenal Medical logo

Arsenal Medical

arsenalmedical.com

Fibralign logo

Fibralign

fibralignbio.com

Woven Orthopedic Technologies logo

Woven Orthopedic Technologies

RegenX logo

RegenX

Artelon - Quick Facts

Who are Artelon's competitors?

Companies similar to Artelon include Atreon Orthopedics, Articulinx, Tela Bio and Artio Medical.

When was Artelon founded?

Artelon was founded in 2013.

Where is Artelon's headquarters located?

Artelon's headquarters is located in Marietta, GA, US.

When was Artelon's last funding round?

Artelon's most recent funding round was for $20M (USD) in May 2023.

How much has Artelon raised to-date?

As of May 24, 2023, Artelon has raised a total of $20M (USD).

How many employees does Artelon have?

Artelon has 5 employees as of Feb 4, 2024.

Artelon - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Revenue
  • Transactional
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 230000Construction
  • 236000Construction of Buildings
SIC
  • 1600Heavy Construction Other Than Building Construction-contractors
  • 1620Heavy Construction, Except Highway And Street Construction
  • 1629Heavy Construction, Not Elsewhere Classified